Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse

Diabetes

Volumn 48, Issue 5, 1999, Pages 989-996

  Sreenan, Seamus ^a   Pick, Anthony J ^a   Levisetti, Matteo ^a   Baldwin, Aaron C ^a   Pugh, William ^a   Polonsky, Kenneth S ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; INSULIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; INSULIN RELEASE; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

AGING; ANIMALS; ARGININE; BLOOD GLUCOSE; BODY WEIGHT; CELL DIVISION; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 0032910989     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.5.989     Document Type: Article

References (26)

1. Eisenbarth GS, Ziegler AG, Colman PA: Pathogenesis of insulin-dependent (type 1) diabetes mellitus. In Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir GC, Eds. Malvern, PA, Lea and Febiger, 1994, p. 216-239
2. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Botazzo GF, Gale EA: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives. Diabetes 43:1304-1310, 1994
3. Eisenbarth GS: Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360-1368, 1986
4. Dotta F, Eisenbarth GS: Type 1 diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of β-cell destruction. Clin Immunol Immunopathol 50:S85-S95, 1989
5. Kano Y, Kanatsuna T, Nakamura N: Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the NOD mouse. Diabetes 36:486-490, 1986
6. Serreze DV, Leiter EH: Genetic and pathogenic basis of autoimmune diabetes mellitus in NOD mice. Curr Opin Immunol 6:900-906, 1984
7. Lampeter EF, Signore EF, Gale EAM, Pozzilli P: Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32:703-708, 1989
8. Tominaga M, Komiya I, Johnson JH, Inman L, Alam T, Moltz J, Crider B, Stefan Y, Baetens D, McCorkle K, Orci L, Unger RH: Loss in insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate. Proc Natl Acad Sci U S A 83:9749-9753, 1986
9. Rudy GB, Sutherland RM, Lew AM: Temporal discontinuities in progression of NOD autoimmune diabetes. Immunol Res 16:137-147, 1997
10. Tochino T. The NOD mouse as a model of type 1 diabetes. CRC Crit Rev Immunol 8:49-81, 1987
11. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG: β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45:1063-1067, 1996
12. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS: Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat Diabetes 47:358-364, 1998
13. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS: Defective insulin secretion in hepatocyte nuclear factor-la-deficient mice. J Clin Invest 101:2215-2222, 1998
14. Montana E, Bonner-Weir S, Weir GC: β-cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest 91:780-787, 1993
15. Signore A, Procaccini E, Toscano AM, Ferretti E, Williams AJK, Beales PE, Cugini P, Pozzilli P: Histological study of pancreatic β-cell loss in relation to the insulitis process in the nonobese diabetic mouse. Histochemistry 101:263-269, 1994
16. Kurrer MO, Pakala SV, Hanson HL, Katz JD: β-cell apoptosis in T-cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 94:213-218, 1997
17. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic mouse. Diabetes 46:750-757, 1997
18. Bonner-Weir S, Deery D, Leahy JL, Weir GC: Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53, 1989
19. Bonner-Weir S: Regulation of pancreatic β-cell mass in vivo. Recent Prog Horm Res 49:91-104, 1994
20. Brockenbrough JS, Weir GC, Bonner-Weir S: Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes 37:232-236, 1988
21. Leahy JL, Cooper HE, Deal DA, Weir GC: Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77:908-915, 1986
22. Leahy JL, Bonner-Weir S, Weir GC: β-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 15:442-453, 1992
23. Rossetti L, Giacarri A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
24. Chatenoud L, Thervert E, Primo J, Bach J-F: Anti-CD3 antibody induces longterm remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91:123-127, 1994
25. Strandell E, Eizirik DL, Sandler S: Reversal of β-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. J Clin Invest 85:1944-1950, 1990
26. Eizirik DL, Strandell E, Sandler S: Prolonged exposure of pancreatic islets isolated from "prediabetic" nonobese diabetic mice to a high glucose concentration does not impair β-cell function. Diabetologia 34:6-11, 1991